. Globocan, Cancer Incidence and Mortality World, 2008.

K. A. Mcglynn and W. T. London, The global epidemiology of hepatocellular carcinoma: present and future, Clinical Liver Disease, vol.15, pp.223-266, 2011.

W. Blonski, D. S. Kotlyar, and K. A. Forde, Non-viral causes of hepatocellular carcinoma, World Journal of Gastroenterology, vol.16, pp.3603-3618, 2010.

N. Nishida and A. Goel, Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review, Currents Genomics, vol.12, pp.130-137, 2011.

Y. D. Kim, C. H. Park, H. S. Kim, C. Sk, J. S. Rew et al., Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma, J Gastroenterol Hepatol, vol.23, pp.110-128, 2008.

C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier et al., Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Natural Genetics, vol.44, pp.694-702, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00719917

H. Huang and X. He, Wnt/beta-catenin signaling: new (and old) players and new insights, Current Opinion in Cell Biology, vol.20, pp.119-144, 2008.

H. Clevers, Wnt/beta-catenin signaling in development and disease, Cell, vol.127, pp.469-80, 2006.

B. M. Gumbiner, Regulation of cadherin-mediated adhesion in morphogenesis, Natural Reviews Molecular Cell Biology, vol.6, pp.622-656, 2005.

V. F. Taelman, R. Dobrowolski, J. L. Plouhinec, L. C. Fuentealba, P. P. Vorwald et al., Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes, Cell, vol.143, pp.1136-1184, 2010.

X. Q. Gan, J. Y. Wang, Y. Xi, Z. L. Wu, Y. P. Li et al., Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction, J Cell Biol, vol.180, pp.1087-100, 2008.

T. Yamashita, A. Budhu, M. Forgues, and X. W. Wang, Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma, Can Res J, vol.67, issue.22, pp.10831-10840, 2007.

E. Provost, Y. Yamamoto, I. Lizardi, J. Stern, T. G. De'aquila et al., Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites, J Biologic Chem, vol.278, pp.31781-31790, 2003.

M. Austinat, R. Dunsch, C. Wittekind, A. Tannapfel, R. Gebhardt et al., Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma, Molecular Cancer, vol.7, p.21, 2008.

K. C. Ban, H. Singh, R. Krishnan, and H. F. Seow, GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma, Cancer Letter, vol.199, pp.201-209, 2003.

M. D. Thompson and S. P. Monga, WNT/beta-catenin signaling in liver health and disease, Hepatology, vol.45, pp.1298-305, 2007.

J. Zucman-rossi, S. Benhamouche, C. Godard, S. Boyault, G. Grimber et al., Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas, Oncogene, vol.26, pp.774-80, 2007.

C. Ozen, G. Yildiz, A. T. Dagcan, D. Cevik, A. Ors et al., Genetics and epigenetics of liver cancer, Natural Biotechnology, vol.30, pp.381-385, 2013.

M. C. Navas, I. Suarez, A. Carreño, D. Uribe, W. A. Rios et al., Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia. Hepatitis Research and Treatment, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00855692

G. Hosny, N. Farahat, H. Tayel, and P. Hainaut, Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases, Cancer Letter, vol.264, pp.201-209, 2008.

C. Li and W. Wong, Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection, Proceedings of the Nationall Academy of Science USA, vol.98, pp.31-37, 2001.

M. D. Thompson and S. P. Monga, WNT/beta-catenin signaling in liver health and disease, Hepatology, vol.45, issue.5, pp.1298-305, 2007.

S. P. Monga, Role of Wnt/ -catenin signaling in liver metabolism and cancer, The International Journal of Biochemistry & Cell Biology, vol.43, pp.1021-1030, 2011.

K. Taniguchi, L. R. Roberts, I. N. Aderca, X. Dong, C. Qian et al., Mutational spectrum of betacatenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas, Oncogene, vol.21, pp.4863-71, 2002.

H. Katoh, T. Shibata, A. Kokubu, H. Ojima, T. Kosuge et al., Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: a case report, Genes Chromosomes Cancer, vol.45, pp.1050-1057, 2006.

S. Garcia, F. Martini, D. Micco, C. Andrac, L. Hardwigsen et al., Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas, International Journal Oncology, vol.12, pp.443-450, 1998.

S. O. Lim, J. M. Gu, M. S. Kim, C. K. Park, J. W. Cho et al., Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter, Gastroenterology, vol.135, pp.2128-2168, 2008.

Y. D. Kim, C. H. Park, H. S. Kim, C. Sk, J. S. Rew et al., Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma, J Gastroenterol Hepatol, vol.23, pp.110-118, 2008.

P. Merle, S. De-la-monte, M. Kim, M. Herrmann, S. Tanaka et al., Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma, Gastroenterology, vol.127, pp.1110-1132, 2004.

O. Kalinina, A. Marchio, A. I. Urbanskii, A. B. Tarkova, K. Rebbani et al., Somatic changes in primary liver cancer in Russia: a pilot study, Mutation Research, vol.755, pp.90-99, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02863297

J. Piedra, D. Martinez, J. Castano, S. Miravet, M. Dunach et al., Regulation of beta-catenin structure and activity by tyrosine phosphorylation, J Biol Chem, vol.276, pp.20436-20479, 2001.

J. Cui, X. Zhou, Y. Liu, Z. Tang, and M. Romeih, Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma, Chinese Medical Journal (Engl), vol.116, pp.1885-92, 2003.

H. C. Hsu, Y. M. Jeng, T. L. Mao, J. S. Chu, P. L. Lai et al., Betacatenin mutations are associated with a subset of lowstage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis, Am J Pathol, vol.157, pp.763-70, 2000.

L. T. Tien, M. Ito, M. Nakao, D. Niino, M. Serik et al., Expression of beta-catenin in hepatocellular carcinoma, World Journal Gastroenterology, vol.11, pp.2398-401, 2005.

M. L. Tornesello, L. Buonaguro, F. Tatangelo, G. Botti, F. Izzo et al., Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections, Genomics, vol.102, pp.74-83, 2013.

H. Su, J. Zhao, Y. Xiong, T. Xu, F. Zhou et al., Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China, Mutation Research, vol.641, pp.27-35, 2008.

C. M. Wong, S. T. Fan, and I. O. Ng, Beta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance, Cancer, vol.92, pp.136-181, 2001.

T. R. Devereux, M. C. Stern, G. P. Flake, M. C. Yu, Z. Q. Zhang et al., CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1, Molecular Carcinogenesis, vol.31, pp.68-73, 2001.

J. Y. Park, W. S. Park, S. W. Nam, S. Y. Kim, S. H. Lee et al., Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis, Liver International, vol.25, pp.70-76, 2005.

F. Cortes-mancera, C. L. Loureiro, S. Hoyos, J. C. Restrepo, G. Correa et al., Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Hepatology Research Treatment, 2011.

P. Laurent-puig, P. Legoix, O. Bluteau, J. Belquiti, D. Franco et al., Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis, Gastroenterology, vol.120, pp.1763-73, 2001.

Y. Ishizaki, S. Ikeda, M. Fujimori, Y. Shimizu, T. Kurihara et al., Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas, International Journal Oncology, vol.24, pp.1077-83, 2004.

Y. Edamoto, A. Hara, W. Biernat, L. Terracciano, G. Cathomas et al., Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis, International Journal of Cancer, vol.106, pp.334-375, 2003.

H. Huang, H. Fujii, A. Sankila, B. M. Mahler-araujo, M. Matsuda et al., Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection, Am J Pathol, vol.155, pp.1795-1801, 1999.

J. Liu, X. Ding, J. Tang, Y. Cao, P. Hu et al., Enhancement of canonical Wnt/ -catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells, PLoS One, vol.6, p.27496, 2011.

Y. Zhang, W. Wei, N. Cheng, K. Wang, B. Li et al., Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling, Hepatology, vol.56, pp.1631-1671, 2012.

H. Takagi, S. Sasaki, H. Suzuki, M. Toyota, R. Maruyama et al., Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma, J Gastroenterol, vol.43, pp.378-89, 2008.

Q. Xie, L. Chen, X. Shan, X. Shan, J. Tang et al., Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway, International Journal of Cancer, vol.135, pp.635-681, 2014.

A. Hsieh, H. S. Kim, S. O. Lim, D. Y. Yu, and G. Jung, Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/ -catenin signaling, Cancer Letter, vol.300, pp.162-72, 2011.

J. M. Lee, J. Yang, P. Newell, S. Singh, A. Parwani et al., Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation, Cancer Letter, vol.343, pp.90-97, 2014.